Literature DB >> 32512677

Comment on: “Treatment of idiopathic granulomatous mastitis and factors related with disease recurrence”

Sami Akbulut1, Tevfik Tolga Şahin1.   

Abstract

Entities:  

Year:  2020        PMID： 32512677      PMCID： PMC7775690          DOI： 10.3906/sag-2005-334

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN： 1300-0144            Impact factor:   0.973


× No keyword cloud information.
  5 in total

Review 1.  Methotrexate in the management of idiopathic granulomatous mastitis: review of 108 published cases and report of four cases.

Authors:  Sami Akbulut; Davut Yilmaz; Sule Bakir
Journal:  Breast J       Date:  2011-09-21       Impact factor: 2.431

Review 2.  Treatments for Idiopathic Granulomatous Mastitis: Systematic Review and Meta-Analysis.

Authors:  Xin Lei; Kai Chen; Liling Zhu; Erwei Song; Fengxi Su; Shunrong Li
Journal:  Breastfeed Med       Date:  2017-07-21       Impact factor: 1.817

Review 3.  Is methotrexate an acceptable treatment in the management of idiopathic granulomatous mastitis?

Authors:  Sami Akbulut; Zulfu Arikanoglu; Ayhan Senol; Nilgun Sogutcu; Murat Basbug; Erhan Yeniaras; Yusuf Yagmur
Journal:  Arch Gynecol Obstet       Date:  2011-01-05       Impact factor: 2.344

4.  Methotrexate-based regimen as initial treatment of patients with idiopathic granulomatous mastitis.

Authors:  Mahbubeh Haddad; Fereshte Sheybani; Mahnaz Arian; Masoumeh Gharib
Journal:  Breast J       Date:  2019-09-08       Impact factor: 2.431

5.  Treatment of idiopathic granulomatous mastitis and factors related with disease recurrence

Authors:  Emre Tekgöz; Seda Çolak; Muhammet Çinar; Sedat Yilmaz
Journal:  Turk J Med Sci       Date:  2020-08-26       Impact factor: 0.973
  5 in total
  1 in total

1.  Idiopathic granulomatous mastitis: challenges of treatment in iranian women.

Authors:  Leyla Shojaee; Nasrin Rahmani; Siavash Moradi; Asieh Motamedi; Gholamali Godazandeh
Journal:  BMC Surg       Date:  2021-04-21       Impact factor: 2.102
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.